Ketamine and Electroconvulsive Therapy: A Case Report
DOI:
https://doi.org/10.25751/rspa.24660Keywords:
Electroconvulsive therapy, Ketamine, Psychotic disorders, Depressive disorder, AnesthesiaAbstract
Electroconvulsive therapy (ECT) is the gold standard therapy for treatment-resistant depression and is usually performed under general anesthesia. A variety of induction agents may be used. Ketamine is an induction agent with increasing evidence suggesting an antidepressant effect. However, ketamine is known to produce psychotic symptoms and therefore its use has been avoided in psychosis. The authors explore the case of a 30-year-old man, who was diagnosed with affective psychosis with predominance of the negative symptoms. He had two major depressive episodes resistant to pharmacological therapy requiring long term permanence in the psychiatry ward and underwent twelve ECT sessions. Ketamine was the most frequently used induction agent. Its use was associated with longer electroconvulsive and motor responses as well as a decremental electrical charge. This treatment regimen led to a sustained remission of depressive symptoms and was not accompanied by psychotic or dissociative phenomena during the treatment and follow-up period.
Downloads
References
Hooten WM, Rasmussen KG. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: A systematic review. J ECT. 2008;24(3):208-223.
da Frota Ribeiro CM, Sanacora G, Hoffman R, et al. The Use of Ketamine for the Treatment of Depression in the Context of Psychotic Symptoms: To the Editor. Biol Psychiatry. 2016;79(9):e65-e66.
Smith-Martinez LA, Chatham LN, Muthukanagaraj P. Intramuscular Ketamine Protocol as an Alternative to Physical Restraints for Electroconvulsive Therapy Administration in a Psychotic Patient: A Case Report. J ECT. 2019;35(1):E1-E2.
Altinay M, Karne H, Anand A. Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double Blind Placebo Controlled Trial. Psychopharmacol Bull. 2019;49(1):8-16.
Zheng W, Li XH, Zhu XM, Cai DB, Yang XH, Ungvari GS, et al. Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials. J Affect Disord. 2019;250:123-131.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Daniela Patricia Trindade Rei Rodrigues Pereira, Catarina Rodrigues e Silva, Ana Sofia Proença Paulino, João Paulo Alvim Gonçalves Pinto Rema
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles are freely available to be read, downloaded and shared from the time of publication.
The RSPA reserves the right to commercialize the article as an integral part of the journal (in the preparation of reprints, for example). The author should accompany the submission letter with a declaration of copyright transfer for commercial purposes.
Articles are published under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC).
After publication in RSPA, authors are allowed to make their articles available in repositories of their home institutions, as long as they always mention where they were published.
